Atlas Venture Opportunity Fund II, L.P. SEC Filing for Disc Medicine, Inc.

Atlas Venture Opportunity Fund II, L.P. has filed a notice with the SEC regarding the sale of securities in Disc Medicine, Inc. The filing details the sale of 35,000 common shares acquired through a private placement on December 17, 2022. The notice, signed by Ommer Chohan on October 17, 2025, also includes information on recent transactions over the past three months, involving significant sales of common shares. The aggregate market value of the securities to be sold is approximately $3,147,900. The filing highlights multiple transactions with gross proceeds ranging from $24,075.25 to $5,078,963.70, indicating substantial activity in the sale of Disc Medicine, Inc. securities.